Amendment Description Amendment Flag Current Fiscal Year End Date Document Period End Date Document Type Entity [Domain] Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Legal Entity [Axis] Investment [Table Text Block] Schedule of investments ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Acquired Finite-Lived Intangible Assets by Major Class [Axis] Payments to Acquire Businesses, Net of Cash Acquired Acquisition of Elan Drug Technologies, net of cash acquired Additional paid-in capital Additional Paid in Capital, Common Stock Amortization of Financing Costs and Discounts Amortization of original issue discount and offering costs Amortization of offering costs and discount Depreciation Depreciation expense Amortization and impairment of acquired intangible assets Amortization of Intangible Assets Asset Retirement Obligation [Abstract] Asset Retirement Obligations Asset Retirement Obligation, Accretion Expense Accretion expense Asset Retirement Obligations, Noncurrent Asset retirement obligation Asset Retirement Obligation Balance at the beginning of the period Balance at the end of the period CONSOLIDATED BALANCE SHEETS Business Acquisition, Cost of Acquired Entity, Purchase Price Total purchase price Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Value of ordinary shares issued as consideration in the acquisition Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net Total Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents Cash Business Acquisition, Purchase Price Allocation, Current Assets, Inventory Inventory Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets Prepaid expenses and other current assets Business Acquisition, Purchase Price Allocation, Current Assets, Receivables Receivables Business Acquisition, Purchase Price Allocation, Current Liabilities Accounts payable and accrued expenses Business Acquisition, Purchase Price Allocation, Goodwill Amount Goodwill Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets Other assets Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment Property plant and equipment Business Acquisition [Axis] Business Acquisition [Line Items] Acquisitions Schedule of Business Acquisitions, by Acquisition [Table] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS - Beginning of period CASH AND CASH EQUIVALENTS - End of period Cash equivalents Cash Equivalents [Member] Interest Paid Cash paid for interest Certificates of Deposit [Member] Certificates of deposit Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Valuation Allowance, Deferred Tax Asset, Change in Amount Decrease in the valuation allowance due to the utilization of NOLs Increase (Decrease) in Receivables Receivables COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares outstanding Common Stock, Shares, Outstanding Common Stock Common Stock, Value, Issued Components of Deferred Tax Assets and Liabilities [Abstract] Components of the company's net deferred tax liabilities COMPREHENSIVE LOSS Comprehensive Income (Loss), Net of Tax, Attributable to Parent Concentration Risk, Percentage Concentration risk percentage Concentration Risk by Type [Axis] Concentration Risk [Line Items] Concentrations Concentration Risk [Table] Corporate Debt Securities [Member] Corporate debt securities Cost of goods manufactured and sold Cost of Goods Sold Credit Concentration Risk [Member] Receivables CURRENT LIABILITIES: Liabilities, Current [Abstract] Total current liabilities Liabilities, Current Customer Concentration Risk [Member] Revenue Long-term Debt, Gross Total Aggregate principal amount of debt issued Debt Instrument, Increase, Additional Borrowings Face amount of term loan facility Debt Instrument, Interest Rate, Effective Percentage Yield to maturity rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Stated interest rate (as a percent) Debt Instrument, Periodic Payment, Principal Required quarterly principal payments Scheduled principal payment Debt Instrument, Unamortized Discount Original issue discount Debt Instrument [Line Items] Long-term debt Schedule of Long-term Debt Instruments [Table] Deferred Income Tax Expense (Benefit) Deferred income taxes Deferred federal and state tax benefit Deferred income tax (benefit) provision Deferred Tax Assets, Deferred Income Deferred revenue Deferred Tax Assets (Liabilities), Net Net deferred tax liabilities Deferred tax liability related to acquired intellectual property Deferred Tax Assets, Net Total deferred tax assets Deferred Tax Assets, Other Other Deferred Tax Assets, Tax Credit Carryforwards Tax credit carryforwards Deferred Tax Assets, Valuation Allowance Less: valuation allowance Deferred Tax Liabilities [Abstract] Deferred tax liabilities : Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets Intangible assets Deferred tax liability related to acquired intellectual property Deferred Tax Liabilities Total deferred tax liabilities Deferred revenue - current Deferred Revenue, Current Deferred revenue, short-term DEFERRED REVENUE - LONG-TERM Deferred Revenue, Noncurrent Deferred revenue, long-term Defined Contribution Plan, Cost Recognized Employer contribution Derivative, Number of Instruments Held Number of contracts Derivative Assets Interest rate cap contracts DERIVATIVE INSTRUMENTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments Not Designated as Hedging Instruments, Loss Loss on derivative instrument due to decreased in value of the contract Derivative [Line Items] Derivative instruments Risk-management instruments Derivative [Table] ACQUISITIONS Business Combination Disclosure [Text Block] Diluted (in dollars per share) Earnings Per Share, Diluted Income (Loss) from Equity Method Investments Reduction in carrying value of investment of the entity, which represents the Company's share of investee's net losses Effective Income Tax Rate, Continuing Operations Effective tax rate (as a percent) Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract] Reconciliation of the company's federal statutory tax rate to its effective rate Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance (as a percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate Statutory federal rate (as a percent) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other Other permanent items (as a percent) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development Research and development benefit (as a percent) Effective Income Tax Rate Reconciliation, Other Adjustments Other (as a percent) Effective Income Tax Rate Reconciliation, State and Local Income Taxes State income taxes, net of federal benefit (as a percent) Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount Share based compensation expense capitalized Allocated Share-based Compensation Expense Total share-based compensation expense Compensation cost recognized Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation Expense Share-based Compensation Share-based compensation expense Equity Method Investments Carrying value of equity investment Equity Method Investment, Ownership Percentage Ownership percentage Cost-method Investments, Aggregate Carrying Amount Investment in Acceleron Pharma, Inc., a collaborative partner Extinguishment of Debt, Amount Redemption of the balance of the debt instrument Domestic Country [Member] Irish Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Finite-lived intangible assets Schedule of Finite-Lived Intangible Assets by Major Class [Table] Finite-Lived Intangible Assets, Amortization Expense Amortization expense Finite-Lived Intangible Assets, Future Amortization Expense Expected amortization of intangible assets Finite-Lived Intangible Assets, Weighted-Average Useful Life Weighted Amortizable Life (in years) Foreign Currency Translation [Abstract] Foreign Currency Foreign Government Debt Securities [Member] International government agency debt securities Gains (Losses) on Extinguishment of Debt Loss on purchase of non-recourse RISPERDAL CONSTA secured 7% Notes Premium paid on redemption of debt CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS INCOME TAXES Income Tax Disclosure [Text Block] Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible assets Intangible Assets, Net (Excluding Goodwill) INTANGIBLE ASSETS - NET Net Carrying Amount Finite-Lived Intangible Assets, Gross Gross Carrying Amount Finite-Lived Intangible Assets, Net [Abstract] Finite-lived intangible assets: Finite-Lived Intangible Assets, Net Net Carrying Amount Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Indefinite-lived intangible assets: Indefinite-Lived Intangible Assets (Excluding Goodwill) Net Carrying Amount Interest expense Interest Expense Interest Rate Cap [Member] Interest rate caps Interest rate cap contracts Interest Rate Swap [Member] Interest rate swap contract Interest rate swap Inventory Inventory, Net Inventory Land [Member] Land Leasehold Improvements [Member] Leasehold improvements LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity [Abstract] TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity Total liabilities Liabilities Licensing Agreements [Member] Collaboration agreements Long-term debt - current Long-term Debt, Current Maturities Less: current portion Long-term Debt, Maturities, Repayments of Principal after Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2013 Long-term Debt, Maturities, Repayments of Principal in Year Five 2017 Long-term Debt, Maturities, Repayments of Principal in Year Four 2016 Long-term Debt, Maturities, Repayments of Principal in Year Three 2015 Long-term Debt, Maturities, Repayments of Principal in Year Two 2014 LONG-TERM DEBT Long-term Debt, Excluding Current Maturities Long-term debt Marketable Securities [Abstract] Total investments INVESTMENTS - LONG-TERM Marketable Securities, Noncurrent Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Net reduction unrecognized tax benefits expected resolution of certain matters Maturities of Long-term Debt [Abstract] Scheduled maturities of Term Loans Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge Maximum hedge period for interest rate protection of debt (in years) Money Market Funds [Member] Money market funds Net Cash Provided by (Used in) Financing Activities Cash flows provided by (used in) financing activities Net Cash Provided by (Used in) Investing Activities Cash flows (used in) provided by investing activities Net Cash Provided by (Used in) Operating Activities Cash flows used in operating activities Proceeds from (Repayments of) Notes Payable Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes NET LOSS Net loss Net Income (Loss) Attributable to Parent Cash and Cash Equivalents, Period Increase (Decrease) NET DECREASE IN CASH AND CASH EQUIVALENTS New Accounting Pronouncements or Change in Accounting Principle [Line Items] New accounting pronouncements New Accounting Pronouncements or Change in Accounting Principle [Table] Total other expense, net Nonoperating Income (Expense) Other Noncash Expense Other non-cash charges Notional Amount of Derivatives Notional value Non-voting Common Stock Nonvoting Common Stock [Member] Operating Leases, Future Minimum Payments Due [Abstract] Future minimum rental commitments under non-cancelable operating leases Operating Leases, Future Minimum Payments Due, Current 2013 Operating Leases, Future Minimum Payments, Due in Five Years 2017 Operating Leases, Future Minimum Payments, Due in Four Years 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2015 Operating Leases, Future Minimum Payments, Due in Two Years 2014 Operating Leases, Future Minimum Payments, Due Thereafter Thereafter Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals Less: estimated sublease income Operating Leases, Future Minimum Payments Due Total future minimum lease payments before estimated sublease income Operating Leases, Rent Expense, Net [Abstract] Rent expense related to operating leases Operating Loss Carryforwards Operating loss carryforwards OPERATING LOSS Operating Income (Loss) Revenue recognized Revenues Revenue by region: Unrealized gains (losses) on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Unrealized gains on marketable securities, net of tax of $372, $225 and $1,831 for the year ended March 31, 2012, 2011 and 2010, respectively Unrealized losses on marketable securities: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax [Abstract] Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax Less: Reclassification adjustment for losses included in net (loss) income Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Proceeds from Issuance of Long-term Debt Proceeds from the issuance of long-term debt Proceeds from Sale and Maturity of Marketable Securities Sales and maturities of investments Proceeds from the sales and maturities of marketable securities Proceeds from Sale of Property, Plant, and Equipment Proceeds from the sale of equipment Proceeds from sale of property, plant and equipment Proceeds from Stock Options Exercised Cash received from option exercises Property, Plant and Equipment, Gross Subtotal PROPERTY, PLANT AND EQUIPMENT PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant and Equipment, Net Total property, plant and equipment, net Payments to Acquire Marketable Securities Purchases of investments Investment in Acceleron Pharmaceuticals, Inc. Payments to Acquire Other Investments Payments to Acquire Property, Plant, and Equipment Additions to property, plant and equipment Receivables Receivables, Net, Current Repayments of Long-term Debt Principal payments of long-term debt Payments for Repurchase of Common Stock Purchase of ordinary shares for treasury Research and Development Arrangement [Member] IPR&D In-process research and development Accumulated deficit Retained Earnings (Accumulated Deficit) Research and development revenue Contracts Revenue REVENUES: Revenue, Net [Abstract] Product sales, net Sales Revenue, Goods, Net Other Other Revenue, Net Total revenues Revenue, Net INVENTORY Inventory Disclosure [Text Block] Secured Debt [Member] Term loan Term loans Investments - short-term Available-for-sale Securities, Debt Securities, Current Selling, general and administrative Selling, General and Administrative Expense Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Nonvested at the beginning of the period (in dollars per share) Nonvested at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Nonvested at the beginning of the period (in shares) Nonvested at the end of the period (in shares) Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition Weighted average period for unrecognized compensation cost expected to be recognized (in years) Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized Unrecognized compensation cost Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value Fair value of RSU's vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Expiration period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Derived service period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Shares of common stock available for issuance Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value Aggregate intrinsic value of stock options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant-date fair value of stock options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at the beginning of the period (in dollars per share) Outstanding at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Estimated dividend yield (as a percent) Expected annual dividend yield (as a percent) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Share-based compensation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Short-term Investments [Member] Short-term investments SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] State and Local Jurisdiction [Member] State U.S. State CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY: Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity Note [Abstract] SHAREHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL CASH FLOW DISCLOSURE: Income Taxes Paid Cash paid for taxes CURRENT ASSETS: Assets, Current [Abstract] Total current assets Assets, Current Trademarks [Member] Trademark Treasury Stock [Member] Treasury Stock Treasury Stock, Shares, Retired Cancellation of treasury stock (in shares) US Government Debt Securities [Member] U.S. government obligations Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations Decreases due to lapse of statute of limitations Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions Additions based on tax positions related to prior periods Unrecognized Tax Benefits that Would Impact Effective Tax Rate Unrecognized tax benefit that would effect effective tax rate Unrecognized Tax Benefits Balance at the beginning of the period Balance at the end of the period Use of Estimates, Policy [Policy Text Block] Use of Estimates Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Write off of Deferred Debt Issuance Cost Charges relating to write-off of the unamortized portion of deferred financing costs Director [Member] Directors Common Stock [Member] Ordinary Shares Construction in Progress [Member] Construction in progress PROPERTY, PLANT AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment, Useful Life, Maximum Estimated useful life, maximum (in years) Property, Plant and Equipment, Useful Life, Minimum Estimated useful life, minimum (in years) Property, Plant and Equipment, Useful Life, Average Estimated useful life (in years) Building and Building Improvements [Member] Building and improvements Property, Plant and Equipment, Disposals Carrying value at the time of disposition Research and development Research and Development Expense Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Changes in the carrying amount of the company's asset retirement obligation Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of the beginning and ending amount of unrecognized tax benefits Available-for-sale Securities, Debt Maturities, within One Year, Fair Value Within 1 year Available-for-sale Securities, Debt Maturities, after One Through Five Years, Fair Value After 1 year through 5 years Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Fair Value After 5 years through 10 years Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Fair Value Total Available-for-sale Securities, Debt Maturities, Fair Value [Abstract] Available-for-sale, Estimated Fair Value Available-for-sale Securities [Abstract] Available-for-sale securities: Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract] Held-to-maturity, Estimated Fair Value Held-to-maturity Securities, Fair Value Estimated Fair Value Restricted Stock [Member] Restricted stock units Stock Options [Member] Stock options Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost Share-based compensation (as a percent) Held-to-maturity Securities, Debt Maturities, within One Year, Fair Value Within 1 year Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Fair Value After 1 year through 5 years Held-to-maturity Securities, Debt Maturities, after Five Through Ten Years, Fair Value After 5 years through 10 years Held-to-maturity Securities, Debt Maturities, Fair Value Total TOTAL ASSETS Assets Interest income Investment Income, Interest OTHER LONG-TERM LIABILITIES Other Liabilities, Noncurrent Concentration Risk by Benchmark [Axis] Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses Gross Unrealized Losses, Less than One Year Held-to-maturity Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Losses Gross Unrealized Losses, Greater than One Year SHARE-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] DEFERRED TAX LIABILITIES - LONG-TERM Deferred Tax Liabilities, Noncurrent Fair Value, by Balance Sheet Grouping [Table] Estimate of Fair Value, Fair Value Disclosure [Member] Total Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Estimated fair value of the Term Loans Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Statement [Table] Statement, Scenario [Axis] Investments, Fair Value Disclosure Estimated Fair Value Derivative Financial Instruments, Liabilities, Fair Value Disclosure Interest rate swap contract Acquired Finite-lived Intangible Asset, Amount Intangible assets acquired, finite-lived Acquired Finite-lived Intangible Asset, Weighted Average Useful Life Estimated useful life of intangible assets acquired (in years) Acquired Indefinite-lived Intangible Asset, Amount Intangible assets acquired, indefinite-lived ASSETS Assets [Abstract] Statement Statement [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Balance at the beginning of the period Balance at the end of the period Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Roll forward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 2 [Member] Level 2 Fair Value, Inputs, Level 3 [Member] Level 3 SHAREHOLDERS' EQUITY FAIR VALUE Fair Value Disclosures [Text Block] Capital Leased Assets, Gross Fully depreciated equipment acquired under capital lease Treasury stock, at cost (35,078 and 10,069,208 shares at March 31, 2012 and 2011, respectively) Treasury Stock, Value Business Acquisition, Cost of Acquired Entity, Purchase Price [Abstract] Purchase price of the EDT business Internal Revenue Service (IRS) [Member] Federal U.S. Federal Basic (in dollars per share) Earnings Per Share, Basic Deferred Tax Assets, Net [Abstract] Deferred tax assets : Excess Tax Benefit from Share-based Compensation, Financing Activities Excess tax benefit from share-based compensation Stockholders' Equity, Period Increase (Decrease) Indefinite-lived Intangible Assets by Major Class [Axis] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Common stock, shares issued Common Stock, Shares, Issued Long-term Debt. Total Carrying Value Deferred Revenue Deferred revenue from milestone payment received prior to April 1, 2011 OTHER ASSETS Other Assets, Noncurrent Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Goodwill, Period Increase (Decrease) Amount of increase to goodwill related to the release of deferred tax valuation allowance Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anitdilutive potential common equivalent shares excluded from calculation of net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Denominator: LOSS PER COMMON SHARE: LOSS PER SHARE Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Purchase Commitment, Remaining Minimum Amount Committed Open purchase order commitments Increase (Decrease) in Other Operating Liabilities Other long-term liabilities Schedule of Equity Method Investments [Table] LOSS BEFORE INCOME TAXES Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before provision for income taxes Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Schedule of Equity Method Investment, Equity Method Investee, Name [Axis] Schedule of Equity Method Investments [Line Items] Equity method investment Goodwill GOODWILL Goodwill recorded in connection with the acquisition of EDT Class of Stock [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Property, Plant and Equipment [Table] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Treasury stock, shares Treasury Stock, Shares Other Comprehensive Income (Loss), Available-for-sale Securities, Tax Unrealized gains on marketable securities, tax Property, Plant and Equipment by Type [Axis] Property, Plant and Equipment [Line Items] Property, plant and equipment Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Other income (expense), net Other Nonoperating Income (Expense) Total shareholders' equity Stockholders' Equity Attributable to Parent BALANCE BALANCE Deferred Tax Liabilities, Property, Plant and Equipment Property, plant and equipment PROVISION (BENEFIT) FOR INCOME TAXES Income Tax Expense (Benefit) Total tax benefit Held-to-maturity Securities, Parenthetical Disclosure [Abstract] Held-to-maturity securities: Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract] Held-to-maturity, Amortized Cost Held-to-maturity Securities, Debt Maturities, within One Year, Net Carrying Amount Within 1 year Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Net Carrying Amount After 1 year through 5 years Held-to-maturity Securities, Debt Maturities, after Five Through Ten Years, Net Carrying Amount After 5 years through 10 years Held-to-maturity Securities, Debt Maturities, Net Carrying Amount Total Preferred stock, par value, $0.01 per share; 50,000,000 and zero shares authorized; none issued and outstanding at March 31, 2012 and 2011, respectively Preferred Stock, Value, Issued US Government Agencies Debt Securities [Member] U.S. government and agency debt securities COMPREHENSIVE LOSS: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Accounts Receivable [Member] Accounts receivable Statement, Equity Components [Axis] Additional Paid-in Capital [Member] Additional Paid-In Capital Retained Earnings [Member] Accumulated Deficit Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Loss (Income) Employee Stock Option [Member] Stock Options LONG-TERM DEBT Long-term Debt [Text Block] Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Issuance of ordinary shares under employee stock plans Stock Issued During Period, Value, Acquisitions Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies Stock Issued During Period, Value, Conversion of Convertible Securities Conversion of non-voting common stock to common stock Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Issuance of ordinary shares under employee stock plans (in shares) Stock Issued During Period, Shares, Acquisitions Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of non-voting common stock to common stock (in shares) Repurchase of common stock for treasury, at cost (in shares) Treasury Stock, Shares, Acquired Inventory, Finished Goods, Net of Reserves Finished goods Inventory, Work in Process, Net of Reserves Work in process Inventory, Raw Materials, Net of Reserves Raw materials Other Inventory, Net of Reserves Consigned-out inventory Stock Issued During Period, Shares, Period Increase (Decrease) Deferred Finance Costs, Gross Offering costs associated with issuance of debt Offering costs Statement, Geographical [Axis] Business Acquisition, Purchase Price Allocation, Other Noncurrent Liabilities Other long-term liabilities COLLABORATIVE ARRANGEMENTS Collaborative Arrangement Disclosure [Text Block] EXPENSES: Costs and Expenses [Abstract] Total expenses Costs and Expenses Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-cash investing and financing activities: Repurchase of common stock for treasury, at cost Treasury Stock, Value, Acquired, Cost Method Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Additional disclosures Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Additional disclosures COMMITMENTS AND CONTINGENCIES (Note 17) Commitments and Contingencies Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Stock options expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Aggregate intrinsic value of stock options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted average remaining contractual term of stock options exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average contractual remaining life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Stock options expected to vest (in shares) Available-for-sale Securities, Fair Value Disclosure Available for sale securities Estimated Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Weighted-average assumptions Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] Additional disclosures Excess tax benefit from share-based compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Products and Services [Axis] Shares, Issued BALANCE (in shares) BALANCE (in shares) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangibles Acquired identifiable intangible assets Intangible assets acquired, total Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Revenues from acquired business Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Net income from acquired business Business Combination, Pro Forma Information [Abstract] Unaudited pro forma information LOSS PER SHARE Earnings Per Share [Text Block] Business Combination, Acquisition Related Costs Expenses related to acquisition WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: Weighted Average Number of Shares Outstanding, Diluted [Abstract] INVESTMENTS Marketable Securities [Text Block] Business Acquisition, Cost of Acquired Entity, Cash Paid Cash paid for acquisition Upfront payment in accordance with the merger agreement Business Acquisition, Cost of Acquired Entity, Equity Interests Issued and Issuable Equity consideration in accordance with the merger agreement Major Customers [Axis] Depreciation, Depletion and Amortization Depreciation and amortization Accounts Payable, Current Accounts payable Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Total accounts payable and accrued expenses Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from the issuance of ordinary shares for share-based compensation arrangements Assets, Fair Value Disclosure Assets, Total Liabilities, Fair Value Disclosure Liabilities, Total Available-for-sale Securities, Gross Unrealized Gains Gross Unrealized Gains Operating Leases, Rent Expense, Net Rent expense Available-for-sale Securities, Amortized Cost Basis Amortized Cost Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Share-based compensation Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Purchased capital expenditures included in accounts payable and accrued expenses Proceeds from Debt, Net of Issuance Costs Net proceeds from issuance of debt Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Investments transferred into Level 3 Accounting Standards Update 2010-13 [Member] ASC 718 Accounting Standards Update 2010-17 [Member] Accounting guidance related to the milestone method of revenue recognition adopted Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents ACCOUNTS PAYABLE AND ACCRUED EXPENSES THE COMPANY INVESTMENTS ACQUISITIONS Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of revenues by geographic location, as determined by the location of the customer, and the location of its long-term assets Fair Value, Hierarchy [Axis] Fair Value by Measurement Frequency [Axis] Schedule of Change in Asset Retirement Obligation [Table Text Block] Schedule of changes in the carrying amount of the company's asset retirement obligation Schedule of Maturities of Long-term Debt [Table Text Block] Scheduled maturities of Term Loans Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of future minimum rental commitments under non-cancelable operating leases Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of components of the company's net deferred tax liabilities Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of components of company's provision (benefit) for income taxes Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of reconciliation of the company's federal statutory tax rate to its effective rate Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of goodwill and intangible assets Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of the Company's assets and liabilities measured at fair value on a recurring basis Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable and accrued expenses Schedule of Purchase Price Allocation [Table Text Block] Purchase price allocation of assets acquired and liabilities assumed Schedule of Inventory, Current [Table Text Block] Schedule of inventories COMMITMENTS AND CONTINGENCIES. INCOME TAXES GOODWILL AND INTANGIBLE ASSETS FAIR VALUE SUBSEQUENT EVENTS Subsequent Events [Text Block] INVENTORY LONG-TERM DEBT Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Summary of time-vested RSU activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of stock option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions DERIVATIVE INSTRUMENTS Held-to-maturity Securities, Amortized Cost before Other than Temporary Impairment Amortized Cost SHARE-BASED COMPENSATION. Asset Retirement Obligations, Policy [Policy Text Block] Asset Retirement Obligations Pension and Other Postretirement Plans, Nonpension Benefits, Policy [Policy Text Block] Employee Benefit Plans Business Acquisition, Pro Forma Information [Table Text Block] Schedule of unaudited pro forma information Business Combinations Policy [Policy Text Block] Business Acquisitions Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Derivatives, Policy [Policy Text Block] Risk-management instruments Consolidation, Policy [Policy Text Block] Principles of Consolidation Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Goodwill and Intangible Assets, Policy [Policy Text Block] Goodwill and Intangible Assets Impairment or Disposal of Long-Lived Intangible Assets, Impairment, Policy [Policy Text Block] Impairment of Long-Lived Assets Income Tax, Policy [Policy Text Block] Income Taxes Inventory, Policy [Policy Text Block] Inventory Investment, Policy [Policy Text Block] Investments Property, Plant and Equipment, Policy [Policy Text Block] Property, Plant and Equipment Research and Development Expense, Policy [Policy Text Block] Research and Development Expenses Revenue Recognition, Policy [Policy Text Block] Revenue Recognition Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of share-based compensation expense Property, Plant and Equipment [Table Text Block] Schedule of estimated useful life of property, plant and equipment Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of revenue and receivables from customers exceeding 10% of total in each category Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Share-Based Compensation Summary of Income Tax Contingencies [Table Text Block] Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Roll forward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs Estimated fair value of term loans Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potential common equivalent shares Earnings Per Share, Policy [Policy Text Block] Loss per Share Stockholders' Equity, Policy [Policy Text Block] Comprehensive Loss Antidilutive Securities, Name [Domain] Business Acquisition, Acquiree [Domain] Class of Stock [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Type [Domain] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Equity Component [Domain] Equity Method Investee, Name [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Income Tax Authority [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Long-term Debt, Type [Domain] Major Types of Debt and Equity Securities [Domain] Major Types of Debt Securities [Domain] Name of Major Customer [Domain] Products and Services [Domain] Property, Plant and Equipment, Type [Domain] Scenario, Unspecified [Domain] Segment, Geographical [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Segment Reporting, Policy [Policy Text Block] Segment Information Stock Repurchase Program, Remaining Authorized Repurchase Amount Value of shares available for repurchase pursuant to repurchase program Stock Repurchase Program, Authorized Amount Value of shares authorized under repurchase program Schedule of Debt [Table Text Block] Schedule of long-term debt Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair value Research and Development Expense [Member] Research and development SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Segment Reporting [Abstract] Segment Information SUBSEQUENT EVENTS Held-to-maturity Securities, Unrecognized Holding Gain Gross Unrealized Gains Type of Adoption [Domain] Noncash or Part Noncash Acquisition, Investments Acquired Investment in Civitas Therapeutics, Inc. Operating Leases, Rent Expense, Sublease Rentals Sublease income Range [Axis] Range [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Ordinary shares issued as consideration in the acquisition Business Acquisition, Pro Forma Revenue Revenues Business Acquisition, Pro Forma Net Income (Loss) Net loss Collaborative Arrangement [Member] Collaboration Agreements Stock Issued Issuance of common stock used in the acquisition of Elan Drug Technologies Derivative Instrument Risk [Axis] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative arrangements Debt Security [Axis] Income Tax Authority [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Maximum Expected option term, maximum (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum Expected option term, minimum (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected stock volatility, minimum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected stock volatility, maximum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period, Minimum Minimum vesting period Investments Classified by Contractual Maturity Date [Table Text Block] The cost and fair value of available-for-sale and held-to-maturity securities by contractual maturity Hedging Designation [Domain] Investment Type Categorization [Domain] Hedging Designation [Axis] Schedule of Operating Leased Assets [Table] Operating Leased Assets [Line Items] Lease Commitments Derivative, Cost of Hedge Cost of interest rate cap Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses Gross Unrealized Losses, Less than One Year Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Losses Gross Unrealized Losses, Greater than One Year Revenue Recognition [Abstract] Revenue Recognition Adjustments for New Accounting Pronouncements [Axis] Investment Holdings [Line Items] Investments Investment Type [Axis] Investment Holdings [Table] Derivatives, Fair Value [Line Items] Fair value of derivatives Derivative Asset, Fair Value, Gross Asset Asset derivative Derivative Liability, Fair Value, Gross Liability Liability derivative Cost of Sales [Member] Cost of goods manufactured and sold Cash Flow Hedging [Member] Designated as cash flow hedge Not Designated as Hedging Instrument [Member] Not designated as hedging instrument Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] Summary of the effect of derivatives designated as hedging instruments on the consolidated statements of operations and comprehensive loss Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Amount of Loss Recorded (Ineffective Portion) Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion Amount Reclassified from Accumulated Other Comprehensive Loss into Earnings (Effective Portion) Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion Amount Recognized in Accumulated Other Comprehensive Loss (Effective Portion) Derivative Contract Type [Domain] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Summary of fair value and presentation in the consolidated balance sheets for derivatives designated and not designated as hedging instruments Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Parent [Member] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash flows from operating activities: Long-term Debt, Type [Axis] THE COMPANY Nature of Operations [Text Block] Accrued compensation Due to Employees, Current Interest Payable, Current Accrued interest Other Accrued Liabilities, Current Accrued other Accounts Payable and Accrued Liabilities, Current [Abstract] Accounts payable and accrued expenses Segment, Geographical, Groups of Countries, Group One [Member] Rest of world Foreign Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment charge Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net [Abstract] Purchase price allocation of assets acquired and liabilities assumed Business Acquisition, Purchase Price Allocation, Deferred Income Taxes, Asset (Liability), Net Deferred tax liabilities Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities, excluding the effect of acquisitions: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Current income tax provision (benefit): Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred income tax (benefit) provision: Income Tax Expense (Benefit), Continuing Operations [Abstract] Components of company's (benefit) provision for income taxes Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: OTHER EXPENSE, NET: Nonoperating Income (Expense) [Abstract] Unrealized losses on derivative contracts, net of tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Unrealized loss on cash flow hedge, net of tax of $(194) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Unrealized loss on cash flow hedge, tax Holding gains (losses), net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) Total unrealized losses included in comprehensive loss Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Shareholders' Equity Increase (Decrease) in Deferred Revenue Deferred revenue Schedule of Revenues from External Customers and Long-Lived Assets [Table] Revenues from External Customers and Long-Lived Assets [Line Items] Geographic Information Long-Lived Assets Total long-term assets by region: Debt Instrument, Description of Variable Rate Basis Variable rate base Variable interest rate base Debt Instrument, Basis Spread on Variable Rate Interest rate, basis spread (as a percent) Type of Arrangement and Non-arrangement Transactions [Axis] Fair Value, Measurements, Recurring [Member] Recurring basis Treasury Stock, Retired, Cost Method, Amount Cancellation of treasury stock Debt Instrument, Fair Value Disclosure Estimated Fair Value Available-for-sale Securities, Debt Maturities, within One Year, Amortized Cost Basis Within 1 year Available-for-sale Securities, Debt Maturities, after One Through Five Years, Amortized Cost Basis After 1 year through 5 years Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Amortized Cost Basis After 5 years through 10 years Available-for-sale Securities, Debt Maturities, Amortized Cost Basis Total Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract] Available-for-sale, Amortized Cost Prepaid Expenses and Other Current Assets Represents the total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Prepaid expenses and other current assets Manufacturing and Royalty Revenues Revenue earned during the period from the sale of goods manufactured and royalty revenues received related to the sale, leasing or otherwise lending to a third party the entity's rights or title to under certain license arrangements. Manufacturing and royalty revenues COLLABORATIVE ARRANGEMENTS Document and Entity Information Increase (Decrease) in Inventory, Prepaid Expenses and Other Assets Inventory, prepaid expenses and other assets Increase (Decrease) In Inventory, prepaid expenses and other assets. Receipt of Company Stock for Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Value Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards. Receipt of Company Stock for the Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Shares Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards (in shares) This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards. Shares acquired by means of net share settlements, related to the vesting of employee stock options to satisfy withholding tax obligations Payment of Non Recourse Product Secured Seven Percent Notes Principal Attributable to Original Issue Discount Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes attributable to original issue discount Represents the payment for purchase of non-recourse RISPERDAL CONSTA secured 7 percent notes attributable to original issue discount. Nonrecourse Secured Notes Principal RISPERDAL CONSTA secured notes (as a percent) Represents RISPERDAL CONSTA secured notes percentage, which is attributable to original issue discount. Inventory Finished Goods Net of Reserves Located at Third Party Warehouse and Shipping Service Provider Finished goods inventory located at third party warehouse and shipping service provider Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale, located at third party warehouse and shipping service provider. Strategic Equity Investments [Member] Strategic equity investments Represents information pertaining to strategic equity investments in corporations and other legal entities represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants. Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 2 to Level 3 Number of investments transferred into level 2 from level 3 Represents the number of investments transferred into level 2 from level 3 of the fair value hierarchy. First Lien Term Loan [Member] First Lien Term Loan Represents the First Lien Term Loan which is due on September 16, 2017 and is secured by a first priority lien on substantially all of the assets and properties of the company and the guarantors. First Lien Term Loan, due September 16, 2017 First Lien Term Loan, due September 16, 2017 Second Lien Term Loan [Member] Second Lien Term Loan Represents the Second Lien Term Loan which is due on September 16, 2018 and is secured by a second priority lien on substantially all of the assets and properties of the company and the guarantors. Second Lien Term Loan, due September 16, 2018 Schedule of Finite-Lived and Indefinite-Lived Intangible Asset by Major Class [Table] Disclosure of the carrying value of finite-lived and indefinite-lived intangible assets, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in operations of a company. Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Intangible assets Intangible Assets Excluding Goodwill Gross Gross Carrying Amount Sum of the gross carrying amounts of all intangible assets, excluding goodwill, before accumulated amortization as of the balance sheet date. Minimum Number of Commercial Drug Products in Portfolio Minimum number of commercial drug products in Company's diversified portfolio Represents the minimum number of commercial drug products in portfolio. Business Combination, Right to Receive Number of Shares Upon Cancellation of Outstanding Shares and Associated Rights of Predecessor Company Right to receive number of shares upon cancellation of outstanding shares and associated rights Represents the right to receive a number of shares upon cancellation of outstanding shares and associated rights of predecessor company in consideration for the business merger. Percentage of Ownership Interest Held by Former Shareholders of Predecessor Company Former shareholders ownership percentage in Alkermes, plc Represents the percentage of ownership of common stock or equity participation held by the former shareholders of predecessor company in the entity upon business merger. Percentage of Interest Held by Wholly Owned Subsidiary of Acquiree Percentage of interest held by wholly owned subsidiary Represents the percentage of ownership of common stock or equity participation held by the wholly owned subsidiary of acquiree in the entity upon business merger. Proceeds and Realized Gain (Loss) on Marketable Securities [Table Text Block] Proceeds from the sales and maturities of marketable securities, plus the resulting realized gains and losses Tabular disclosure of the proceeds from sales and maturities of marketable securities, plus the resulting realized gains and losses. Long-term Investments [Member] Long-term investments Represents information pertaining to long-term investments. Strategic Investments [Member] Strategic investments Represents information pertaining to strategic investments. Marketable Securities at Amortized Cost Amortized Cost Represents the cost of debt and equity securities, which are categorized as held-to-maturity, trading securities and available-for-sale, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Marketable Securities Gross Unrealized Gains Gross Unrealized Gains Represents the gross unrealized gains for securities, at a point in time, which are categorized as held-to-maturity, trading securities and available-for-sale securities. Marketable Securities Continuous Unrealized Loss Position Less than 12 Months Aggregate Losses Gross Unrealized Losses, Less than One Year Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for less than twelve months for those securities that are categorized as held-to-maturity, trading securities and available-for-sale. Marketable Securities Continuous Unrealized Loss Position 12 Months or Longer Aggregate Losses Gross Unrealized Losses, Greater than One Year Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for twelve months or longer for those securities that are categorized as held-to-maturity, trading securities and available-for-sale. Marketable Securities Realized Gain Realized gains Represents the profit realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale. Marketable Securities Realized Loss Realized losses Represents the loss realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale. Civitas Therapeutics Inc [Member] Civitas Represents information pertaining to Civitas Therapeutics, Inc. Equity Method Investee Preferred Stock Shares Issued Shares of Series A preferred stock issued Represents the total number of preferred shares issued by the equity method investee. Equity Method Investee Proceeds from Preferred Stock Shares Issued Proceeds from issuance of shares of Series A preferred stock Represents the proceeds from issuance of preferred shares issued by the equity method investee. Equity Method Investment Percentage of Preferred Stock Shares Received Percentage of Series A preferred stock received by the entity Represents the percentage of preferred shares, issued by the equity method investee, received by the entity. Equity Method Investment Deferred Gain (Loss) Increase in carrying value of equity method investment Represents the amount of gain on equity method investment which has been deferred. Equity Method Investment Amortization Period of Deferred Gain Period of amortization of deferred gain (in years) Represents the period over which the gain on equity method investment will be amortized. Furniture, fixture and equipment Furniture Fixture and Equipment [Member] Represents furniture, fixture and equipment of the entity. Selling General and Administrative [Member] Selling, general and administrative The allocation (or location) of expenses to (in) selling general and administrative expense. Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Plan Name [Axis] Pertinent data describing and reflecting required disclosures pertaining to an equity-based compensation arrangement, by plan. Share-based Compensation Arrangements by Share-based Payment Award, Plan Name [Domain] Equity-based compensation plans, including multiple equity-based payment arrangements. Stock Option and Incentive Plan 2011 [Member] 2011 Plan Represents the 2011 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company. Share-based Compensation Arrangement by Share-based Payment Award Number of Plans under which No Further Awards Will be Made Number of share-based compensation plans under which no further awards will be made Represents the number of equity-based compensation plans under which no further awards will be made. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Options Count Against Number of Shares Available for Grant Ratio Numerator Numerator for the ratio of awards other than stock options counted against the total number of shares available for issuance Represents the numerator for the ratio of awards other than stock options counted against the total number of shares available for issuance. Share-based Compensation Arrangement by Share-based Payment Award Equity Instrument Other than Options Count Against Number of Shares Available for Grant Ratio Denominator Denominator for the ratio of awards other than stock options counted against the total number of shares available for issuance Represents the denominator for the ratio of awards other than stock options counted against the total number of shares available for issuance. Award Type [Axis] Information by award type pertaining to equity-based compensation. Share-based Compensation Arrangement by Share-based Payment Award Options Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Time Vested Restricted Stock Units [Member] Time-vested RSUs Represents the time-vested restricted stock units awarded by the company to its employees as a form of incentive compensation. Performance-based Restricted Stock Units [Member] Performance-based RSU's Represents performance based restricted stock units as awarded by a company to their employees as a form of incentive compensation. Plan 2006 [Member] 2006 Plan Represents information pertaining to 2006 plan. Plan 2002 [Member] 2002 Plan Represents information pertaining to 2002 plan. Share-based Compensation Arrangement by Share-based Payment Award Equity Instruments Other than Options Nonvested Weighted Average Grant Date Fair Value [Roll Forward] Weighted Average Grant Date Fair Value Number of share-based compensation plans under which awards are currently made Represents the number of equity-based compensation plans under which awards are currently made. Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Under which Awards are Currently Made Schedule of Marketable Securities [Axis] Represents the number of concepts which capture the general categories of investments that may be classified as available-for-sale, held-to-maturity and trading and the information required and determined to be disclosed in relation to these categories or to additional categories or specific debt and equity investments. Marketable Securities [Domain] Provides the general categories of investments that may be classified as available-for-sale, held-to-maturity and trading, for which information is required or is determined to be disclosed. Business Acquisition Cost of Acquired Entity [Table Text Block] Schedule of purchase price of the EDT business Disclosure of the total purchase price for the acquisition. Schedule of Acquired Intangible Assets [Table Text Block] Summary of intangible assets acquired Tabular disclosure of the major classes of acquired intangible assets. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company. Elan Drug Technologies [Member] EDT Represents information pertaining to Elan Drug Technologies. Business Acquisition Equity Interests Issued or Issuable Closing Price Per Share Closing stock price (in dollars per share) Represents the closing price per share of equity interests (such as common shares or preferred shares) issued as consideration to acquire the entity. Business Acquisition Number of Principal Drug Technology Platforms Number of principal drug technology platforms Represents the number of principal drug technology platforms acquired by the entity. Business Acquisition Pro Forma Earnings Per Share Basic and Diluted Basic and diluted loss per common share The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of the period. Intangible Assets Acquired as Part of Business Combination [Table] A table containing detailed characteristics of finite-lived and indefinite-lived intangible assets acquired during a business combination. Intangible assets are assets that have no physical form. Acquired finite-lived and indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total. Intangible Assets Acquired as Part of Business Combination [Line Items] Intangible assets acquired Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of operations and comprehensive loss Derivative Instrument Gain (Loss) [Abstract] Concentration Risk, Credit Risk [Policy Text Block] Concentrations Disclosure of accounting policy for credit risk. New Accounting Pronouncements Policy [Policy Text Block] New Accounting Pronouncements Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting. Cash Equivalents Original Maturity Period Maximum Maximum original maturity period of investments classified as cash equivalents (in months) Represents the maximum original maturity period of investments classified as cash equivalents. Represents information pertaining to Cephalon, Inc. Cephalon Cephalon Inc [Member] Represents information pertaining to VIVITROL, a product of the entity. VIVITROL VIVITROL [Member] The London Interbank Offered Rate (LIBOR) used to calculate the variable interest rate of the debt instrument. LIBOR Debt Instrument Variable Rate Base, LIBOR [Member] Aggregate revenues, net, during the period in the normal course of business. Revenues, net Revenues, Net [Member] Defined contribution 401 (k) plan. 401 (K) Plan Plan 401 (K) [Member] Identification of the reference rate that is used to calculate the variable interest rate of the debt instrument. Debt Instrument Variable Rate Base [Domain] Name of the defined contribution plan. Defined Contribution Benefit Plans [Domain] Defined Contribution Plan Represents the defined contribution plan for employees outside the reporting entity's home country. Foreign Defined Contribution Plans [Member] Schedule of Defined Contribution Benefit Plans Disclosures [Table] Disclosures about defined contribution plans. Defined Contribution Benefit Plans, Disclosure Benefit Plans [Axis] Disclosures about defined contribution plan. Collaborative Arrangements, Termination, Net Collaborative Profit Recognized Net collaborative profit recognized upon termination of the collaboration Represents the amount of net collaborative profit recognized related to the termination of the collaborative agreement. Collaborative Arrangements, Termination Unearned Milestone Revenue Unearned milestone revenue Represents the amount of unearned milestone revenue recognized due to the termination of the collaborative agreement. Collaborative Arrangements, Deferred Revenue Remaining at Termination Date Deferred revenue remaining at the termination date Represents the amount of deferred revenue recognized at the termination date of the collaborative agreement. Proceeds Received to Fund Share of Product Losses for Specified Period from Termination Date Proceeds received to fund Cephalon's share of its estimated losses during the one-year period following the termination date Represents the amount of proceeds received from collaborative partner to fund its share of estimated product losses during the specified period from the collaborative agreement termination date. Period Following Termination Date for Which Product Losses Funded Period following the termination date for which Cephalon has funded its estimated losses (in years) Represents the period following the collaborative agreement termination date for which the collaborative partner has funded its share of estimated product losses. Revenue Recognition, Milestone Method, Revenue Recognized upon Achievement of Developmental Milestones Revenue recognized upon the achievement of developmental milestones The amount of consideration recognized during the period for the achievement of developmental milestones. Revenue Recognition Milestone Method Revenue Recognized Upon Achievement of Milestones with No Remaining Performance Obligations Revenue recognized upon the achievement of milestones with no remaining performance obligations The amount of consideration recognized during the period for the achievement of milestones with no remaining performance obligations. Revenue Recognition, Milestone Method, Potential Future Payments for Development Milestone Aggregate potential future payments for development milestone Represents the amount of potential future payments for development milestones. Manufacturing Profit Percentage Percentage of manufacturing profit recorded as revenue Represents the percentage of manufacturing profit. Threshold for Disclosure Percentage Threshold percentage for disclosure of revenue and receivables The minimum percentage of revenues or receivables from a single customer that is used as a threshold for disclosure of a concentration of risk. Defined Contribution Plan, Employer Matching Contribution Percent Percentage of employer contribution matched of the first 6% of employee pay Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Defined Contribution Plan, Maximum Percentage of Participant Compensation Eligible for Employer Matching Contribution Percentage of employee pay matched 50% by employer Represents the maximum percentage of participants' eligible compensation for employer matching contribution. Debt Instrument Variable Rate Base [Axis] The alternative reference rates that may be used to calculate the variable interest rate of the debt instrument. Vesting Rights Percentage Vesting rights per year (as a percent) Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, shown as a percentage. Defined Contribution Benefit Plans [Line Items] Employee benefit plans Schedule of Share-based Compensation Arrangement by Title of Individual [Axis] Reflects the pertinent provisions pertaining to equity-based compensation arrangement, by individual. Schedule of Share-based Compensation Arrangement by Title of Individual with Relationship to Entity [Domain] Title of the individual (or the nature of the entity's relationship with the individual) who is party to the equity-based compensation arrangement. Debt Instrument Maturity Period Term loans maturity period (in years) Represents the maturity period of debt instrument. Debt Instrument Variable Rate Base [Member] Base rate Represents the base rate used to calculate the variable rate of the debt instrument. Debt Instrument Interest Rate Floor Interest rate floor (as a percent) Represents the interest rate floor for the variable rate base of the debt instrument. Percentage of Prepayment Premium on Term Loan If Prepayment is Made in Connection with Refinancing Transaction Percentage of prepayment premium on term loans being repaid if the prepayment is made in connection with a refinancing transaction Represents the percentage of prepayment premium on term loans being repaid if the prepayment is made in connection with a refinancing transaction. Percentage of Prepayment Premium of Outstanding term Loan Balance if Prepayment is Made in Connection with Amendment to Agreement Resulting in Refinancing Transaction Percentage of prepayment premium on outstanding term loan balance if prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction Represents the percentage of prepayment premium on the outstanding term loan balance if the prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction. Debt Instrument Incremental Capacity Subject to Satisfaction of Certain Conditions Incremental capacity Represents the amount of incremental capacity available so long as the entity meets certain conditions. Nonrecourse RISPERDAL CONSTA Secured 7 Percent Notes [Member] Non-Recourse RISPERDAL CONSTA Secured 7% Notes Represents the non-recourse RISPERDAL CONSTA secured notes bearing 7 percent interest rate. Royalty Sub LLC [Member] Royalty Sub Represents RC Royalty Sub LLC, a former wholly-owned subsidiary of the entity. Debt Instrument Redemption Price as Percentage of Principal Outstanding Redemption price as a percentage of outstanding principal balance Represents the redemption price as a percentage of outstanding principal balance of the debt instrument. Stock Repurchase Program Additional Authorized Amount Value of additional shares authorized under the 2007 repurchase program The amount of additional shares authorized by the entity's board of directors under a stock repurchase plan. Shares Acquired as Payment of Exercise Price of Stock Options Granted for Share-based Compensation Shares acquired as payment of the exercise price of stock options granted Represents the number of shares acquired by the entity as payment of the exercise price of stock options granted under the entity's equity compensation plans. Shares Paid for Tax Withholding for Share-based Compensation Average Cost Per Share Average price of shares acquired by means of net share settlements, related to the vesting of employee stock options to satisfy withholding tax obligations (in dollars per share) Represents the cost of shares acquired by means of net share settlement of share-based awards when the employer settles the employees' income tax withholding obligation, divided by the total number of shares acquired. Shares Acquired as Payment of Exercise Price of Stock Options Granted for Share-based Compensation Average Cost Per Share Average price of shares acquired as payment of the exercise price of stock options granted (in dollars per share) Represents the cost of shares acquired by the entity as payment of the exercise price of stock options granted under the entity's equity compensation plans, divided by the total number of shares acquired. Operating Lease Term Term of operating leases (in years) Represents the term of the operating lease. Operating Lease Provision for Extension of Term Provisions for extension of lease term (in years) Represents the provision for extension of operating lease term. Operating Leases Future Minimum Payments Due Net of Sublease Total future minimum lease payments The total of future contractually required payments on leases, net of related future sublease operating rental income receivable. Purchase Commitments [Abstract] Purchase commitments License and Royalty Commitment [Abstract] License and Royalty Commitments License Fees and Royalties Paid Amount paid under license agreements Represents the amount of annual license fees and royalties paid by the entity under licensing arrangements. Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options Tax benefit from the exercise of stock options The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. Additional tax benefits from stock option exercises that have not been recognized Operating Loss and Capital Loss Carryforwards Amount of operating loss and tax credit carryforwards subject to annual limitation Represents the annual limitation of operating loss and tax credit carryforwards, before tax effects, that may be utilized to reduce future taxable income under enacted tax laws. Income Taxes [Table] Disclosures pertaining to income taxes. Income Taxes [Line Items] Income taxes Distribution of net loss before provision for income taxes Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options Including Additional Tax Benefits Total tax benefit from the exercise of stock options including unrecognized benefits related to the adoption of ASC 718. The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. This element includes the additional tax benefits from the exercise of stock options related to the adoption of ASC 718, that have not been recognized in the financial statements. Current State and Local Tax Expense from Transfer of Intellectual Property Provision on taxable transfer of the BYDEREON intellectual property The component of income tax expense for the period representing amounts paid or payable as determined by applying the provisions of enacted state and local tax law to the amount of taxable transfer of intellectual property. Current Federal Tax Benefit for Bonus Depreciation Pursuant to Small Business Jobs Act 2010 Tax benefit for bonus depreciation pursuant to the Small Business Jobs Act of 2010 The component of income tax expense for the period representing amounts refundable for bonus depreciation pursuant to the Small Business Jobs Act of 2010 as determined by applying the provision of enacted federal tax law to the domestic taxable income or loss from continuing operations. Deferred Income Tax Benefit Increase in Fair Value of Securities Income tax expense associated with the increase in the value of certain securities The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to increase in fair value of securities. Deferred Federal Income Tax Benefit in Connection with Business Combination Tax benefit in connection with the Business Combination The component of total income tax expense for the period comprised of an increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to business combination as determined by applying the provisions of the US federally enacted tax law. Number of business segments Number of Business Segments Represents the number of business segments of the entity. Defined Contribution Plan Employee Contribution Limit as Percentage of Compensation Employee contribution limit as a percentage of their eligible compensation The limit of annual employee contributions to the plan, as a percentage of compensation. Debt Instrument Required Principal Payments as Percentage of Excess Cash Flows Beginning Next Fiscal Year Required principal payments as a percentage of excess cash flows beginning next fiscal year Represents the amount of required principal payment as a percentage of excess cash flows beginning next fiscal year. Debt Instrument Percentage of Loans Required to be Covered by Hedge Agreements Percentage of aggregate principal amount of debt required to be covered under hedge agreements Represents the percentage of aggregate principal amount of debt required to be covered under the hedge agreements. Unrecognized Tax Benefits that would Impact Effective Tax Rate Related to Deferred tax Asset Unrecognized tax benefit that would effect effective tax rate related to deferred tax asset The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate, related to deferred tax assets for which full valuation allowance would be recorded. Collaborative Arrangements Number of Units of Accounting Into which Deliverables are Separated Number of units of accounting into which deliverables are separated Represents the number of units of accounting into which deliverables are separated for purpose of revenue recognition under the collaborative agreement. Operating Loss Carryback Period Operating loss carryback period (in years) Represents the operating loss carryback period. Operating Loss Carryback Period Pursuant to Enacted Law Operating loss carryback period pursuant to Worker, Homeownership and Business Act of 2009 (in years) Represents the operating loss carryback period pursuant to enacted law. Deferred federal and state tax benefit The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's domestic, state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of applicable enacted tax law. Deferred Federal, State and Local, Income Tax Expense Benefit Nano Crystal Technology [Member] NanoCrystal technology The value associated with NanoCrystal technology, an intangible asset acquired from third parties. OCR Technology [Member] OCR technology The value associated with OCR technology, an intangible asset acquired from third parties. Proceeds From Sale of Rights of Licensing Manufacturing and Supply Agreement to Wholly Owned Subsidiary Proceeds received from a wholly owned subsidiary from the sale and assignment of the rights to collect certain royalty payments and manufacturing fees Represents the proceeds received from a wholly owned subsidiary from the sale and assignment of the rights to collect certain royalty payments and manufacturing fees earned under the license and manufacturing and supply agreements with Janssen. Premium paid on redemption of debt Extinguishment of Debt Premium Represents the premium paid on the extinguishment of debt. Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type [Axis] Pertinent data describing and reflecting required disclosures pertaining to an equity-based compensation arrangement, by award type. Share-based Compensation Arrangements by Share-based Payment Award, Award Type [Domain] Equity-based compensation award type, including multiple equity-based payment arrangements. Represents the number of investments transferred into level 3 from level 1 of the fair value hierarchy. Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 1 to Level 3 Number of investments transferred into level 3 from level 1 License agreement License Agreement [Member] Represents information pertaining to the license agreement included under the collaboration agreement. Manufacturing and supply agreement Manufacturing and Supply Agreement [Member] Represents information pertaining to the manufacturing and supply agreement included under the collaboration agreement. Development and supplemental agreement Development and Supplemental Agreement [Member] Represents information pertaining to the development and supplemental agreement included under the collaboration agreement. Development and license agreement Development and License Agreement [Member] Represents information pertaining to the development and license agreement included under the collaboration agreement. License and commercialization agreement License and Commercialization Agreement [Member] Represents information pertaining to the license and commercialization agreement included under the collaboration agreement. Janssen [Member] Janssen Represents Janssen, a collaborative partner of the entity. Acorda [Member] Acorda Represents Acorda, a collaborative partner of the entity. Amylin [Member] Amylin Represents Amylin, a collaborative partner of the entity. Cilag [Member] Cilag Represents Cilag, a collaborative partner of the entity. RISPERDALCONSTA [Member] RISPERDAL CONSTA Represents information pertaining to RISPERDAL CONSTA, a product of the entity. INVEGASUSTENNAOrXEPLION [Member] INVEGA SUSTENNA/XEPLION Represents information pertaining to INVEGA SUSTENNA/XEPLION, a product of the entity. AMPYRAOrFAMPYRA [Member] AMPYRA/FAMPYRA Represents information pertaining to AMPYRA/FAMPYRA, a product of the entity. BYDUREON [Member] BYDUREON Represents information pertaining to BYDUREON, a product of the entity. Collaborative Arrangement Royalty Rate Royalty rate (as a percent) Represents royalty as a percentage of net sales under the collaborative agreements. Collaborative Arrangement Effective Notice Period Required to be Served for Termination of Agreement Notice period required to be given before termination of agreement Represents the notice period required to be served before the termination of the agreement. Collaborative Arrangement Period after Date of First Commercial Sale of Product for Expiration of Agreement Period after the date of the first commercial sale of the product for license expiration (in years) Represents the period after the date of the first commercial sale of the product in a particular country that the agreement will expire. Collaborative Arrangement Period for Resolving Default or Breach After Receipt of Notice for Termination of Agreement Period for resolving default or breach after the receipt of notice for termination of agreement (in days) Represents the period for resolving default or breach after the receipt of notice for termination of agreement. Collaborative Arrangement Royalty Rate Upon Termination of Related Agreement Royalty rate upon termination of manufacturing and supply agreement (as a percent) Represents royalty rate upon termination of related agreement. Collaborative Arrangement Percentage of Total Annual Requirement of Product That Can be Obtained from Second Source Manufacturer Percentage of total annual requirement of product that can be obtained from second source manufacturer Percentage of total annual requirement of product that can be obtained from second source manufacturer under the collaborative agreement. Collaborative Arrangement Milestone Payment Received Milestone payment received by the entity Represents the amount of milestone payment received by the entity under the collaborative agreement. Collaborative Arrangement Royalty Rate for Specified Number of Units Royalty as a percentage of net sales from the first 40 million units Represents royalty as a percentage of net sales of specified number of units under the collaborative arrangement. Collaborative Arrangement Royalty Rate Beyond Specified Number of Units Royalty as a percentage of net sales beyond the first 40 million units Represents royalty as a percentage of net sales beyond specified number of units under the collaborative agreement. Collaborative Arrangement Number of Units Sold Threshold for Determination of Royalty Rate Threshold for number of units sold used to determine royalty rate Represents the threshold for the number of units sold which is used to determine the royalty rate under the collaborative agreement. Collaborative Arrangement Additional Milestone Payments Eligible Upon Receipt of Regulatory Approvals Amount of additional milestone payments eligible upon receipt of regulatory approvals for the product Represents the amount of additional milestone payments eligible upon receipt of regulatory approvals for the product under the collaborative agreement. Collaborative Arrangement Period after Effective Date for Right to Terminate Agreement Number of years after the effective date of the agreement, which gives Cilag a right to terminate the agreement Represents the period after the effective date of the agreement, which gives the counterparty a right to terminate the agreement. Collaborative Arrangement Effective Notice Period Required to be Served for Termination of Agreement Due to Change in Pricing and Reimbursement Notice period required to be given before termination of agreement due to change in pricing and/or reimbursement (in days) Represents the notice period required to be served before the termination of the agreement due to change in pricing and reimbursement. Collaborative Arrangement Extension Period for Resolving Default or Breach after Receipt of Notice for Termination of Agreement Extension period for resolving default or breach after the receipt of notice for termination of agreement (in days) Represents the extension period for resolving default or breach after the receipt of notice for termination of agreement. Schedule of Property, Plant and Equipment Components [Table Text Block] Tabular disclosure of the components of property, plant and equipment. Schedule of property, plant and equipment License and Collaboration Agreement and Supply Agreement [Member] Represents information pertaining to the license and collaboration agreement and supply agreement. License and collaboration agreement and supply agreement Countries [Axis] Represents information pertaining to all countries. All Countries [Domain] UNITED STATES United States U.S IRELAND Ireland Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers into Level 3 from Level 1 Investments transferred into Level 3 from Level 1 Transfers into assets measured at fair value from Level 1 and categorized within Level 3 of the fair value hierarchy that have taken place during the period. Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers into Level 3 from Level 2 Investments transferred into Level 3 from Level 2 Transfers into assets measured at fair value from Level 2 and categorized within Level 3 of the fair value hierarchy that have taken place during the period. Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out of Level 3 to Level 2 Investments transferred out of Level 3 To Level 2 Transfers out of assets measured at fair value and categorized within Level 3 of the fair value hierarchy that have taken place during the period to level 2. Indefinite-lived Intangible Assets Excluding Goodwill Gross Gross carrying amount Gross amount of assets (excluding financial assets) that lack physical substance, excluding goodwill, having a projected indefinite period of benefit. Indefinite Lived Intangible Assets, Excluding Goodwill, Accumulated Impairment Loss Accumulated Amortization The accumulated impairment losses as of the balance sheet related to intangible assets, excluding goodwill, having a projected indefinite period of benefit. Intangible Assets, Net Excluding Goodwill Accumulated Amortization and Impairment Loss Accumulated Amortization The accumulated amortization and impairment losses related to intangible assets, excluding goodwill as of the balance sheet date. Geographic Information [Policy Text Block] Geographic Information Disclosure of the entity's accounting policy for geographic information. Defined Contribution Plan, Maximum Employee Contribution Limit As Percentage of Total Taxable Earnings Maximum employee contribution limit as a percentage of their total taxable earnings The limit of annual employee contributions to the plan, as a percentage of their total taxable earnings. Defined Contribution Plan, Annual Contribution by Per Employee Amount Per employee contribution limit Maximum amount per employee, by the terms of the plan, that the employee may contribute to a defined contribution plan. Revenue Recognition Milestone Method Substantive Amount of Future Potential Payments to be Recognized as Milestones Achieved Substantive amount of future potential payments that are expected to be recognized as revenue when milestones are achieved Represents the substantive amount of future potential payments that are expected to be recognized as revenue when milestones are achieved. Stock Option and Incentive Plan 2008 [Member] 2008 Plan Represents the 2008 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company. Schedule of Net Income (Loss) Before Provision for Taxes by Geographical Area [Table Text Block] Schedule of net loss before provision for income taxes by geographical area Tabular disclosure of net income or loss before provision for income taxes by geographical area of the entity. Reversal of Deferred Tax Liability Relating to Acquired Intellectual Property Tax benefit from partial release of the Irish deferred tax liability related to acquired intellectual property Represents the tax benefit from partial release of the deferred tax liability related to acquired intellectual property created in connection with business combination. Unremitted Earnings of Foreign Subsidiaries Cumulative unremitted earnings of overseas subsidiaries Represents the cumulative unremitted earnings of overseas subsidiaries as of the end of the period. Operating Loss and Tax Credit Carryforwards Annual Limitation Amount of operating loss and tax credit carryforwards subject to annual limitation. Represents the annual limitation of operating loss and tax credit carryforwards, before tax effects, that may be utilized to reduce future taxable income under enacted tax laws. Percentage of employer contribution matched up to the first 5% of employee pay Percentage of employees' gross pay for which the employer contributes a matching contribution up to the first 5 percent of employee pay to a defined contribution plan. Defined Contribution Plan, Employer Matching Contribution Percent for UpTo First 5 Percent of Employee Pay Percentage of employee pay matched 100% by employer Represents the maximum percentage of participants' eligible compensation for employer 100 percent matching contribution. Defined Contribution Plan, Maximum Percentage of Participant Compensation Eligible for Employer 100 Percent Matching Contribution Minimum Period after Loss, Carryforwards Utilized that Tax Returns Remain Open to Examination Represents the minimum period after loss carryforwards have been utilized that tax returns remain open to examination. Minimum period after loss carryforwards utilized that tax returns remain open to examination (in years) Maximum Period after Loss Carryforwards Utilized that Tax Returns Remain Open to Examination Represents the maximum period after loss carryforwards have been utilized that tax returns remain open to examination. Maximum period after loss carryforwards utilized that tax returns remain open to examination (in years) Number of investments transferred into level 3 from level 2 Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 3 to Level 2 Represents the number of investments transferred into level 3 from level 2 of the fair value hierarchy. Defined Contribution Plan Employer Matching Contribution Percent, Maximum Maximum percentage of employer contribution matched of employee's taxable earnings Maximum percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Research and Development Arrangement Related to Three Elan Drug Technologies [Member] IPR&D related to three EDT Represents information pertaining to in-process research and development related to Elan Drug Technologies. Number of Products Number of products Represents the number of products. Gain on foreign currency translation Foreign Currency Transaction Gain (Loss), before Tax Current income tax provision (benefit) Current Income Tax Expense (Benefit) Internal Revenue Service IRS Member and State and Local Jurisdiction [Member] Federal, State, and Local Represents the designated tax departments of the United States of America and state and local government entitled to levy and collect income taxes from the entity. Alkermes Europe Ltd [Member] Alkermes Europe Ltd Represents information pertaining to Alkermes Europe, Ltd. Deferred Tax Assets Operating Loss Carry forwards NOL carryforwards Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential Receipt of Company Stock in Shares to Satisfy Withholding Tax Obligations This element represents receipt of Alkermes' stock shares acquired to satisfy tax withholding obligations. Net share settlements of ordinary shares to satisfy withholding tax obligations Deferred Tax Liability Related to Acquired Intellectual Property Represents the deferred tax liability related to acquired intellectual property. Deferred tax liability related to acquired intellectual property